← Leaderboards
Giovanni Manfredi
Icahn School Of Medicine At Mount Sinai
$21,254,007
Attributed
$26,466,440
Total exposure
17
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$26,466,440 · 17
By mechanism
R01$18,048,742 · 8
R35$5,477,228 · 1
R21$1,629,744 · 4
K02$761,526 · 1
K23$529,200 · 1
R13$20,000 · 2
Top collaborators
- Doris A Germain13 shared
- Steven S Gross5 shared
- Costantino Iadecola5 shared
- Lorenz P. Studer5 shared
- Hibiki Fujita2 shared
- Marilena D'Aurelio1 shared
- Gerald S Shadel1 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Doris A Germain$10,430,941
- Michelle Suzanne Mazei-Robison$3,588,945
Others in their field
Top investigators on “Mitochondria”
- Bruce M Spiegelman · Dana-Farber Cancer Inst$30,163,696
- Shi Du Yan · Columbia University Health Sciences$29,685,201
- Peipei Ping · University Of California Los Angeles$27,344,561
- Mary McGrae McDermott · Northwestern University$25,752,019
- Vamsi Krishna Mootha · Massachusetts General Hospital$23,004,991
- Kenneth D. Tew · Fox Chase Cancer Center$22,000,362
Research focus
MitochondriaProteinsCellsAffectMitochondrial DysfunctionGeneticResponsePathogenesisMutantPathway InteractionsDefectNeuronsPlayTissuesMouse ModelMolecularMutationBiochemicalCalciumCell TypeHomeostasisCessation Of LifeGenetic TranscriptionIn Vivo
Grant awards (74)
Mitochondrial Integrated Stress Response in Neurological Diseases$1,101,750
R35 · FY2025 · NS · contact PI
Raloxifene-Based Therapy in Neuro Degenerative Diseases$330,538
R01 · FY2025 · NS
Targeting GDF15-GFRAL signaling in mitochondrial myopathies$216,113
R21 · FY2025 · AR
2025 Mitochondria in Health and Disease Gordon Research Conference and Gordon Research Seminar$15,000
R13 · FY2025 · NS · contact PI
Mitochondrial Integrated Stress Response in Neurological Diseases$1,068,698
R35 · FY2024 · NS · contact PI
Raloxifene-Based Therapy in Neuro Degenerative Diseases$356,247
R01 · FY2024 · NS
Mitochondrial Integrated Stress Response in Neurological Diseases$1,101,748
R35 · FY2023 · NS · contact PI
Raloxifene-Based Therapy in Neuro Degenerative Diseases$367,264
R01 · FY2023 · NS
Mitochondrial Integrated Stress Response in Neurological Diseases$17,898
R35 · FY2023 · NS · contact PI
Mitochondrial Integrated Stress Response in Neurological Diseases$1,101,750
R35 · FY2022 · NS · contact PI
Raloxifene-based therapy in neuro degenerative diseases$269,363
R01 · FY2022 · NS
Raloxifene-based therapy in neuro degenerative diseases$98,697
R01 · FY2022 · NS
Mitochondrial Integrated Stress Response in Neurological Diseases$87,378
R35 · FY2022 · NS · contact PI
Mitochondrial Integrated Stress Response in Neurological Diseases$998,006
R35 · FY2021 · NS · contact PI
Raloxifene-based therapy in neuro degenerative diseases$543,749
R01 · FY2021 · NS
The role of the mitochondrial protein dimer CHCHD2/10 in health and disease$425,531
R01 · FY2020 · NS · contact PI
Estrogen receptor beta and mitochondrial permeability transition in Ca2+-induced neuronal injury$370,781
R01 · FY2020 · NS · contact PI
The role of the mitochondrial protein dimer CHCHD2/10 in health and disease$69,480
R01 · FY2020 · NS · contact PI
Metabolic profiling of sporadic ALS patients: from fibroblasts to neurons and back$530,987
R01 · FY2019 · NS · contact PI
The role of the mitochondrial protein dimer CHCHD2/10 in health and disease$425,531
R01 · FY2019 · NS · contact PI
Mitochondria quality control in SOD1-ALS$370,781
R01 · FY2019 · NS · contact PI
Estrogen receptor beta and mitochondrial permeability transition in Ca2+-induced neuronal injury$370,781
R01 · FY2019 · NS · contact PI
Targeting the mitochondrial UPR in familial ALS.$211,875
R21 · FY2019 · NS
Targeting astrocytic toxicity for ALS therapy$211,875
R21 · FY2019 · NS
Metabolic profiling of sporadic ALS patients: from fibroblasts to neurons and back$530,987
R01 · FY2018 · NS · contact PI
Mitochondrial inter membrane space-IMS unfolded protein response in familial ALS$370,782
R01 · FY2018 · NS
Estrogen receptor beta and mitochondrial permeability transition in Ca2+-induced neuronal injury$370,781
R01 · FY2018 · NS · contact PI
Mitochondria quality control in SOD1-ALS$370,781
R01 · FY2018 · NS · contact PI
Targeting the mitochondrial UPR in familial ALS.$271,625
R21 · FY2018 · NS
Targeting astrocytic toxicity for ALS therapy$254,250
R21 · FY2018 · NS
Metabolic profiling of sporadic ALS patients: from fibroblasts to neurons and back$530,987
R01 · FY2017 · NS · contact PI
Mitochondrial inter membrane space-IMS unfolded protein response in familial ALS$370,782
R01 · FY2017 · NS
Mitochondria quality control in SOD1-ALS$370,781
R01 · FY2017 · NS · contact PI
Estrogen receptor beta and mitochondrial permeability transition in Ca2+-induced neuronal injury$370,781
R01 · FY2017 · NS · contact PI
Metabolic profiling of sporadic ALS patients: from fibroblasts to neurons and back$530,987
R01 · FY2016 · NS · contact PI
Mitochondrial inter membrane space-IMS unfolded protein response in familial ALS$370,782
R01 · FY2016 · NS
Mitochondria quality control in SOD1-ALS$370,781
R01 · FY2016 · NS · contact PI
Estrogen receptor beta and mitochondrial permeability transition in Ca2+-induced neuronal injury$370,781
R01 · FY2016 · NS · contact PI
Metabolic profiling of sporadic ALS patients: from fibroblasts to neurons and back$548,362
R01 · FY2015 · NS · contact PI
Mitochondrial inter membrane space-IMS unfolded protein response in familial ALS$370,782
R01 · FY2015 · NS
Mitochondria quality control in SOD1-ALS$370,781
R01 · FY2015 · NS · contact PI
Mitochondrial inter membrane space-IMS unfolded protein response in familial ALS$388,157
R01 · FY2014 · NS
Mitochondrial calcium homeostasis in SOD1-familial ALS$358,670
R01 · FY2014 · NS · contact PI
Modulation of Oxidative phosphorylation by mitochondrial soluble adenylyl cyclase$354,900
R01 · FY2014 · GM · contact PI
Impaired amino acid metabolism in mitochondrial diseases$209,756
R21 · FY2014 · NS · contact PI
Mitochondrial calcium homeostasis in SOD1-familial ALS$349,614
R01 · FY2013 · NS · contact PI
Defects of mitochondrial dynamics in ALS$346,365
R01 · FY2013 · NS · contact PI
Modulation of Oxidative phosphorylation by mitochondrial soluble adenylyl cyclase$342,479
R01 · FY2013 · GM · contact PI
Impaired amino acid metabolism in mitochondrial diseases$254,250
R21 · FY2013 · NS · contact PI
Mitochondrial Biogenesis and Dynamics in Health, Disease and Aging$5,000
R13 · FY2013 · GM
Mitochondrial calcium homeostasis in SOD1-familial ALS$362,294
R01 · FY2012 · NS · contact PI
Defects of mitochondrial dynamics in ALS$359,026
R01 · FY2012 · NS · contact PI
Modulation of Oxidative phosphorylation by mitochondrial soluble adenylyl cyclase$354,900
R01 · FY2012 · GM · contact PI
Mitochondrial calcium homeostasis in SOD1-familial ALS$362,294
R01 · FY2011 · NS · contact PI
Defects of mitochondrial dynamics in ALS$359,120
R01 · FY2011 · NS · contact PI
Modulation of Oxidative phosphorylation by mitochondrial soluble adenylyl cyclase$354,900
R01 · FY2011 · GM · contact PI
Mitochondrial calcium homeostasis in SOD1-familial ALS$369,688
R01 · FY2010 · NS · contact PI
Defects of mitochondrial dynamics in ALS$362,879
R01 · FY2010 · NS · contact PI
Modulation of Oxidative phosphorylation by mitochondrial soluble adenylyl cyclase$354,900
R01 · FY2010 · GM · contact PI
Defects of mitochondrial dynamics in ALS$380,718
R01 · FY2009 · NS · contact PI
Modulation of Oxidative phosphorylation by mitochondrial soluble adenylyl cyclase$354,900
R01 · FY2009 · GM · contact PI
The Pathogenic Mechanisms of Mutant SOD1 in Mitochondria$293,630
R01 · FY2009 · NS · contact PI
The Pathogenic Mechanisms of Mutant SOD1 in Mitochondria$293,630
R01 · FY2008 · NS · contact PI
Modulation of ATP synthesis in mitochondrial disorders$129,510
K02 · FY2008 · NS · contact PI
The Pathogenic Mechanisms of Mutant SOD1 in Mitochondria$293,630
R01 · FY2007 · NS · contact PI
Modulation of ATP synthesis in mitochondrial disorders$117,504
K02 · FY2007 · NS · contact PI
The Pathogenic Mechanisms of Mutant SOD1 in Mitochondria$302,400
R01 · FY2006 · NS · contact PI
Modulation of ATP synthesis in mitochondrial disorders$171,504
K02 · FY2006 · NS · contact PI
Modulation of ATP synthesis in mitochondrial disorders$171,504
K02 · FY2005 · NS
Modulation of ATP synthesis in mitochondrial disorders$171,504
K02 · FY2004 · NS
ATP SYNTHESIS IN MITOCHONDRIAL DISORDERS$132,300
K23 · FY2003 · NS
ATP SYNTHESIS IN MITOCHONDRIAL DISORDERS$132,300
K23 · FY2002 · NS
ATP SYNTHESIS IN MITOCHONDRIAL DISORDERS$132,300
K23 · FY2001 · NS
ATP SYNTHESIS IN MITOCHONDRIAL DISORDERS$132,300
K23 · FY2000 · NS